These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7779366)

  • 1. Definition of minimum standards for immunogenicity--potential problems of serological correlates--possible interference. Serological correlates for diphtheria-tetanus-whole cell pertussis vaccines.
    Heron I
    Biologicals; 1994 Dec; 22(4):389-90. PubMed ID: 7779366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
    Durbacă S; Andronescu C; Diaconescu A
    Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
    Diao L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antibody titers in eleven- to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids.
    Okada K; Ueda K; Morokuma K; Fukushige J; Miyazaki C
    Pediatr Infect Dis J; 1998 Dec; 17(12):1167-9. PubMed ID: 9877371
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines: World Health Organization versus Federal Drug Administration recommended formula.
    Khalil MK; al-Mazrou YY; al-Ghamdi YS
    East Mediterr Health J; 2000 Jul; 6(4):644-51. PubMed ID: 11794070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
    Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization responses in preterm infants who receive postnatal steroid treatment.
    Berrington J; Fenton A
    Pediatrics; 2004 Oct; 114(4):1127-8; author reply 1128-9. PubMed ID: 15466119
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age.
    Booy R; Aitken SJ; Taylor S; Tudor-Williams G; Macfarlane JA; Moxon ER; Ashworth LA; Mayon-White RT; Griffiths H; Chapel HM
    Lancet; 1992 Feb; 339(8792):507-10. PubMed ID: 1346876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse reactions and immune response to Heberbiovac-HB vaccine administered to infants simultaneously with DPT and VA-MENGOC-BC].
    Díaz González M; Rodríguez Lay L; López-Chávez AU; Bravo González JR; Pedroso Flaquet P
    Rev Cubana Med Trop; 1997; 49(3):196-203. PubMed ID: 9685987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes.
    Soria-Guerra RE; Rosales-Mendoza S; Moreno-Fierros L; López-Revilla R; Alpuche-Solís AG
    Plant Cell Rep; 2011 Mar; 30(3):417-24. PubMed ID: 21188384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Observation of the serological effect and immune resistance of 2-dose immunization with adsorbed DTP].
    Xie GZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1987 Jun; 8(3):139-42. PubMed ID: 2888535
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of the ADTP-vaccine immunization of children with different courses of the vaccinal period].
    Sliusar' LI; Romanenko TA; Dubil'er Zhi ; Panasenko LI; Litvinova TP
    Pediatriia; 1992; (10-12):22-5. PubMed ID: 1291954
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of the immune response in children having different HLA phenotypes after the first revaccination with ADTP].
    Prilutskiĭ AS; Maĭlian EA; Radomskaia FS; Filippova TI; Eremin NM; Laricheva LN; Matveĭchuk LF; Klimenko TM; Karpenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):86-8. PubMed ID: 7879562
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.